Iaso Therapeutics

Pre-clinical

Cambridge, United StatesFounded 2020iasotherapeutics.com

Develops immunotherapies and targeted therapies for autoimmune diseases and cancer.

Market Cap

Private

Pipeline

—

Patents

—

Publications

—

Private Company

Total funding raised: $26.8M

Develops immunotherapies and targeted therapies for autoimmune diseases and cancer.

Vaccines

Total raised:$26.8M

Series A$22MUndisclosedAug 15, 2023

Seed$4.8MUndisclosedNov 15, 2021